Article
Clinical manifestations of intermediate allele carriers in Huntington disease.
Neurology - 9 Aug 2016
Cubo Esther, Ramos-Arroyo María A, Martinez-Horta Saul, Martínez-Descalls Asunción, Calvo Sara, Gil-Polo Cecilia
Abstract excerpt
OBJECTIVE: There is controversy about the clinical consequences of intermediate alleles (IAs) in Huntington disease (HD). The main objective of this study was to establish the clinical manifestations of IA carriers for a prospective, international, European HD registry. METHODS: We assessed a cohort of participants at risk with <36 CAG repeats of the huntingtin (HTT) gene. Outcome measures were the Unified...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
